Why Gilead's new hepatitis C drug is a game changer — price and all
June 28, 2016 at 15:25 PM EDT
The Foster City company has taken heat for its groundbreaking hepatitis C treatments. Its new drug comes in at $900 a day, but is the first to cover all subtypes of the liver disease in a once-a-day tablet.
